PT-141 (Bremelanotide) 10 mg
Selective MC3R/MC4R agonist — FDA-approved reference compound. ≥98% purity, 10 mg lyophilized. For laboratory research only.
🎟️ Available Coupons
AURA-BOGO 🛍️ Frequently Bought Together
- Dispatch within 24-48 Hours : Your product will be shipped quickly.
Description
Research Profile
As an FDA-approved pharmaceutical (Vyleesi®), Bremelanotide is one of the most clinically validated melanocortin peptides. Unlike peripheral vasodilators, PT-141 acts centrally through hypothalamic melanocortin-4 receptor activation, modulating dopaminergic and oxytocinergic signaling. Research continues to explore its unique central mechanism of action and downstream neuroendocrine effects.








Reviews
There are no reviews yet.